Follow us on:
Breaking News
July 10, 2026
CP Direct: Friday Edition
Breaking News
FederalEquipment_ENL_070326_650x90
Next Week at Contract Pharma
SGS_Webinar_07-16-26_NextWeek@

The Friday Brief for July 10, 2026: Companies and Facilities Changing Hands

 
The Friday Brief for July 10, 2026: Companies and Facilities Changing Hands

July wasted no time setting a brisk pace for pharma wheelings and dealings.
Watch Now >>

Top Headlines

Breaking News

Olon Completes Major Concord Facility Expansion

Doubles production capacity and strengthens commercial manufacturing capabilities at the Concord, Ohio site.

SPONSOR

[VideoBite] How to Reduce Risk Before Your Next Pharma Product Transfer

Product transfers are a minefield of delays and compliance gaps. PLD Pharma Services' VP of R&D explains the R&D and regulatory strategies that keep transfers on track.

SPONSOR

3D-Printed Tablets Are Here. Are You Ready?

3D printing is disrupting traditional drug manufacturing. Register for this July 22 webinar and get ahead of the shift.

Breaking News
Promotions & Moves

Biohaven Announces Scientific Leadership Changes

Davird Pirman promoted to EVP and Head of Discovery; Bruce Car transitions to Chief Innovation Officer; Warren Volles designated Executive Officer.

Breaking News

Gattefossé Accelerates Production Ramp-up at Lufkin Facility

Three pharmaceutical excipients now manufactured in Texas include Peceol, Compritol 888, and Geleol Mono and Diglycerides NF.

SPONSOR

New eBook: Elevating Quality and Compliance in Sterile Injectable Fill-Finish

Learn strategies for managing evolving GMP expectations, reducing contamination risk, and supporting advanced biologics and drug-device production.

ProBio_Webinar_08-27-26_650x250

Breaking News

Fujifilm Holly Springs Selected for FDA PreCheck Pilot

North Carolina facility becomes one of seven sites chosen to support manufacturing readiness and faster regulatory reviews.

Online Exclusives

Ardena Highlights the Biopharma Industry’s Shift Toward Integrated Support

Henny Zijlstra, CCO, Ardena, discusses sponsor demand for streamlined development, regional redundancy and connected bioanalytical data.

SPONSOR

Flexibility in Drug Development: From Tactical Response to Strategic Discipline

How strategic flexibility enables continuity, scalability, and reliable execution in modern drug development.

Featured Resources

Solution Content Center SPOTLIGHT

Vetter Pharma International

Vetter is a leading and independent global CDMO for the aseptic production of injectables. Its roots and headquarters are in Ravensburg, Germany. Vetter has been a stable, reliable family-owned company since its establishment as a pharmacy in 1950, now with more than 7,400 skilled and dedicated employees.

 

Solution Center SPOTLIGHT

Lannett CDMO

Lannett CDMO is a US-based contract manufacturing organization with decades of pharmaceutical experience. We specialize in oral solid dose and non-injectable liquid manufacturing, high-potency compounds, and controlled substances. Our comprehensive services include advanced analytics, regulatory support, and supply chain management.